Global healthcare technology company Medtronic has partnered with the Institute of Neurosciences Kolkata (I-NK) to strengthen the management of Parkinson’s disease and other movement disorders through advanced neuromodulation therapies, with a focus on training, awareness and clinical capability building.
The collaboration will promote skill development among medical professionals and increase awareness about therapy options for conditions such as Parkinson’s disease, dystonia and tremors. According to medical data, Parkinson’s disease prevalence in East India, especially in Kolkata, stands at around 45.82 per 100,000 people, with a significant number of early-onset cases before the age of 50. Neuromodulation therapies such as Deep Brain Stimulation (DBS) and newer innovations like adaptive DBS (aDBS) are increasingly being used for selected patients to improve motor symptoms.
Medtronic India Managing Director and Vice President Mandeep Singh Kumar said the partnership aims to build sustainable clinical capabilities in West Bengal. “Neuromodulation care demands a high degree of clinical precision alongside informed patient engagement, and this collaboration will help strengthen treatment pathways for Parkinson’s disease,” he said.
The collaboration reflects the growing importance of Kolkata healthcare sector, which is emerging as a key hub for advanced neurological care in eastern India. With rising awareness and increasing cases of neurological disorders such as Parkinson’s disease, hospitals and healthcare providers in Kolkata are expanding specialised treatment capabilities. Industry observers note that partnerships between global medical technology firms and specialised institutions in the city are likely to accelerate adoption of advanced therapies and strengthen the region’s role in India’s evolving neuromodulation ecosystem.
Dr Hrishikesh Kumar, Vice Chairman and Head of Neurology and Director of the Movement Disorders Program at I-NK, said increasing awareness among clinicians and patients is crucial as neuromodulation becomes an important part of neurological care. Doctors Bibhukalyani Das, Jacky Ganguly, Amit Kumar Ghosh and Supriyo Choudhury also stressed the need for a Centre of Excellence for neuromodulation in eastern India, noting that India’s large population carries a higher burden of Parkinson’s disease.
